TW96, a synthetic 1,4-naphthoquinone, differentially regulates vascular and endothelial cells survival

Vascular Pharmacology

Volumn 51, Issue 4, 2009, Pages 225-235

  Aviv, Yaron ^a   Etzion, Sharon ^a   Win, Thida ^a   Bittner, Shmuel ^a   Granot, Yossi ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

BAX; MAPKs; Migration arrest; Naphthoquinone; ROS

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 PYRRILIDINO 3 (4 HYDROXYPHENYLAMINO) 1,4 NAPHTHOQUINONE; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; TW 96; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BAX GENE; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; IN-STENT RESTENOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DEATH; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; MUSCLE, SMOOTH, VASCULAR; NAPHTHOQUINONES; RATS;

EID: 70349883688     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.06.007     Document Type: Article

References (60)

1. Aam B.B., Myhre O., and Fonnumm F. Transcellular signalling pathways and TNF-alpha release involved in formation of reactive oxygen species in rat alveolar macrophages exposed to tert-butylcyclohexane. Arch. Toxicol. 77 (2003) 678-684
2. Adachi M., Fukuda M., and Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. Embo J. 18 (1999) 5347-5358
3. Aharonovitz O., and Granot Y. Stimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. Differential effect of phorbol ester and vasopressin. J. Biol. Chem. 271 (1996) 16494-16499
4. 2- in vascular smooth muscle cells. Circ. Res. 77 (1995) 29-36
5. Baines C.P., Goto M., and Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell Cardiol. 29 (1997) 207-216
6. Barilli A., Visigalli R., Sala R., Gazzola G.C., Parolari A., Tremoli E., Bonomini S., Simon A., Closs E.I., Dall'Asta V., and Bussolati O. In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. Cardiovasc. Res. 78 (2008) 563-571
7. Betriu A., Masotti M., Serra A., Alonso J., Fernandez-Aviles F., Gimeno F., Colman T., Zueco J., Delcan J.L., Garcia E., and Calabuig J. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J. Am. Coll. Cardiol. 34 (1999) 1498-1506
8. Cerutti P.A. Prooxidant states and tumor promotion. Science 227 (1985) 375-381
9. Chang H.C., Tsai S.Y., Wu G.J., Lin Y.H., Chen R.M., and Chen T.L. Effects of propofol on mitochondrial function and intracellular calcium shift in bovine aortic endothelial model. Acta Anaesthesiol. Sin. 39 (2001) 115-122
10. Drachman D.E., Edelman E.R., Seifert P., Groothuis A.R., Bornstein D.A., Kamath K.R., Palasis M., Yang D., Nott S.H., and Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J. Am. Coll. Cardiol. 36 (2000) 2325-2332
11. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
12. Finkel T. Redox-dependent signal transduction. FEBS Lett. 476 (2000) 52-54
13. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15 (2003) 247-254
14. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
15. Fiorani M., Cantoni O., Tasinato A., Boscoboinik D., and Azzi A. Hydrogen peroxide- and fetal bovine serum-induced DNA synthesis in vascular smooth muscle cells: positive and negative regulation by protein kinase C isoforms. Biochim. Biophys. Acta 1269 (1995) 98-104
16. Granot Y., Erikson E., Fridman H., Van Putten V., Williams B., Schrier R.W., and Maller J.L. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J. Biol. Chem. 268 (1993) 9564-9569
17. Hao H., Gabbiani G., and Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1510-1520
18. Huang S.T., Kuo H.S., Hsiao C.L., and Lin Y.L. Efficient synthesis of 'redox-switched' naphthoquinone thiol-crown ethers and their biological activity evaluation. Bioorg. Med. Chem. 10 (2002) 1947-1952
19. Inbaraj J.J., and Chignell C.F. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 17 (2004) 55-62
20. Jin Y.-R., Hwang K.-A., Cho M.-R., Kim S.-Y., Kim J.-H., Ryu C.-K., Son D.-J., Park Y.-H., and Yun Y.-P. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative. Vasc. Pharmacol. 41 (2004) 35
21. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
22. Kawamura F., Hirashima N., Furuno T., and Nakanishi M. Effects of 2-methyl-1,4-naphtoquinone (menadione) on cellular signaling in RBL-2H3 cells. Biol. Pharm. Bull. 29 (2006) 605-607
23. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
24. Khokhlatchev A.V., Canagarajah B., Wilsbacher J., Robinson M., Atkinson M., Goldsmith E., and Cobb M.H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93 (1998) 605-615
25. Kim T.J., Jeon J., Jin Y.R., Son D.J., Yoo H.S., Hong J.T., Ryu C.K., Shin H.S., Lee K.H., and Yun Y.P. Effects of KTJ740, a novel antithrombotic agent, on platelet-derived growth factor-induced rat aortic smooth muscle cell proliferation and cell cycle progression. J. Cardiovasc. Pharmacol. 49 (2007) 280-286
26. Kim T.J., and Yun Y.P. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Vasc. Pharmacol. 46 (2007) 43-51
27. Kipshidze N., Dangas G., Tsapenko M., Moses J., Leon M.B., Kutryk M., and Serruys P. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J. Am. Coll. Cardiol. 44 (2004) 733-739
28. Kockx M.M., and Knaapen M.W. The role of apoptosis in vascular disease. J. Pathol. 190 (2000) 267-280
29. Li P.F., Dietz R., and von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett. 404 (1997) 249-252
30. Mason R.P., and Chignell C.F. Free radicals in pharmacology and toxicology-selected topics. Pharmacol. Rev. 33 (1981) 189-211
31. Matsubayashi Y., Fukuda M., and Nishida E. Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J. Biol. Chem. 276 (2001) 41755-41760
32. McCord J.M. Human disease, free radicals, and the oxidant/antioxidant balance. Clin. Biochem. 26 (1993) 351-357
33. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., and Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42 (1994) 75-80
34. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
35. Ollinger K., and Brunmark A. Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes. J. Biol. Chem. 266 (1991) 21496-21503
36. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., and Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270 (1995) 7420-7426
37. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., and Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6 (1999) 842-854
38. Ryu C.K., Choi K.U., Shim J.Y., You H.J., Choi I.H., and Chae M.J. Synthesis and antifungal activity of 6-arylthio-/6-arylamino-4,7-dioxobenzothiazoles. Bioorg. Med. Chem. 11 (2003) 4003-4008
39. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J.H., Yagita H., Okumura K., Doi T., and Nakano H. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. Embo J. 22 (2003) 3898-3909
40. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003) 769-773
41. Saraste A., and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45 (2000) 528-537
42. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
43. Schreihofer D.A. Transcriptional regulation by phytoestrogens in neuronal cell lines. Mol. Cell Endocrinol. 231 (2005) 13-22
44. Schulze P.C., De Keulenaer G.W., Yoshioka J., Kassik K.A., and Lee R.T. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ. Res. 91 (2002) 689-695
45. Schwartz S.M., deBlois D., and O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77 (1995) 445-465
46. Simpson P., and Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 50 (1982) 101-116
47. Sugie S., Okamoto K., Rahman K.M., Tanaka T., Kawai K., Yamahara J., and Mori H. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 127 (1998) 177-183
48. Sumbayev V.V., and Yasinska I.M. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch. Biochem. Biophys. 436 (2005) 406-412
49. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
50. Takekawa M., Posas F., and Saito H. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. Embo J. 16 (1997) 4973-4982
51. Tao L., Gao E., Hu A., Coletti C., Wang Y., Christopher T.A., Lopez B.L., Koch W., and Ma X.L. Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br. J. Pharmacol. 149 (2006) 311-318
52. Taylor R.P., and Starnes J.W. Age, cell signalling and cardioprotection. Acta Physiol. Scand. 178 (2003) 107-116
53. Thomas M.J. The molecular basis of growth hormone action. Growth Horm. IGF Res. 8 (1998) 3-11
54. Tsujimoto A., Takemura G., Mikami A., Aoyama T., Ohno T., Maruyama R., Nakagawa M., Minatoguchi S., and Fujiwara H. A therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 48 (2006) 160-165
55. Vanden Berghe T., Kalai M., Denecker G., Meeus A., Saelens X., and Vandenabeele P. Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal 18 (2006) 328-335
56. Vlahos C.J., McDowell S.A., and Clerk A. Kinases as therapeutic targets for heart failure. Nat. Rev. Drug Discov. 2 (2003) 99-113
57. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
58. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., and Iwao H. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 795-801 Electronic publication 2003 Mar 2013
59. Zhou X., Zhai X., and Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 93 (1996) 1177-1184
60. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014